Results
90
90 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
EXAS | US$65.96 | -5.9% | -3.3% | US$12.6b | US$77.57 | PS4.7x | E70.9% | n/a | ||
INCY | US$65.83 | 0.1% | 14.0% | US$12.5b | US$74.17 | PE130.3x | E41.1% | n/a | ||
INSM | US$72.48 | -2.3% | 187.0% | US$12.5b | US$87.50 | PS37.9x | E53.7% | n/a | ||
MANKIND | ₹2,592.00 | 2.2% | 44.4% | ₹1.0t | ₹2,445.07 | PE52.9x | E16.5% | n/a | ||
TECH | US$78.72 | 0.5% | 15.6% | US$12.4b | US$83.09 | PE74.3x | E18.3% | 0.4% | ||
ERF | €57.90 | 10.3% | 8.2% | €11.1b | €60.34 | PE34x | E18.4% | 0.9% | ||
500257 | ₹2,221.50 | 3.2% | 89.6% | ₹1.0t | ₹1,994.20 | PE44.8x | E18.7% | 0.4% | ||
SRPT | US$124.53 | -2.1% | 2.7% | US$11.9b | US$194.36 | PE251.1x | E44.1% | n/a | ||
NBIX | US$115.06 | -2.8% | 2.3% | US$11.7b | US$168.72 | PE34.3x | E29.3% | n/a | ||
REC | €50.75 | 1.6% | 13.5% | €10.4b | €53.49 | PE26.8x | E10.8% | 2.4% | ||
SOBI | SEK 326.20 | 2.3% | 46.0% | SEK 112.3b | SEK 325.55 | PE52.3x | E25.9% | n/a | ||
4523 | JP¥5,525.00 | -4.0% | -33.5% | JP¥1.6t | JP¥7,459.19 | PE47.9x | E16.2% | 2.9% | ||
BRKR | US$70.67 | 4.6% | 13.4% | US$10.7b | US$79.74 | PE30.4x | E20.8% | 0.3% | ||
AUROPHARMA | ₹1,511.35 | 1.0% | 65.3% | ₹877.8b | ₹1,558.78 | PE24.9x | E12.4% | 0.2% | ||
IPN | €111.50 | -0.2% | -10.2% | €9.2b | €127.19 | PE13.9x | E7.0% | 1.1% | ||
CRL | US$198.31 | -3.6% | 1.2% | US$10.2b | US$224.01 | PE23.7x | E12.7% | n/a | ||
MEDP | US$331.44 | -9.4% | 36.9% | US$10.1b | US$389.47 | PE30.2x | E13.5% | n/a | ||
QGEN | US$45.24 | 0.8% | 8.4% | US$10.0b | US$50.97 | PE138.3x | E37.1% | n/a |